Pacific Biosciences of California, ... (PACB)

$12

+0.52 (+4.53%)
Rating:
Recommendation:
Neutral
Symbol PACB
Price $12
Beta 1.594
Volume Avg. 4.54M
Market Cap 2.955B
Shares () -
52 Week Range 3.85-14.2
1y Target Est -
DCF Unlevered PACB DCF ->
DCF Levered PACB LDCF ->
ROE -42.23% Strong Sell
ROA -16.45% Sell
Operating Margin -
Debt / Equity 190.29% Buy
P/E -
P/B 4.31 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PACB news


Dr. Michael Hunkapiller
Healthcare
Medical Devices
NASDAQ Global Select

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.